Latest News

In episode 83 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to provide an update on guidelines for statin use in people with HIV based on results from the REPRIEVE trial. Dr Grinspoon is a Professor of Medicine at Harvard Medical School and a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center [...]

In episode 82 of Going anti-Viral, Dr Tyler Evans joins host Dr Michael Saag to discuss the Ebola outbreak in the Democratic Republic of the Congo and Uganda and the global response. Dr Evans is an infectious diseases and addiction medicine physician and CEO of Wellness Equity Alliance, a national organization advancing health equity in the [...]

The final presentation slides, podcasts, and on-demand webcasts from the virtual course, Applying Emerging Antiretroviral Data to Clinical Practice: A Case-Based Program, are now available. Click Here To View

The March/April 2026 issue of Topics in Antiviral Medicine™ (TAM) is now available at https://www.iasusa.org/tam/march-april-2026/. This issue offers up to 12.25 CME credits and includes 9 articles showcasing the latest data from the 2026 Conference on Retroviruses and Opportunistic Infections. Selected Highlights of the 2026 Conference on Retroviruses and Opportunistic Infections CROI 2026: Basic Science Highlights From the […]

Registration is now open for the 2026 Ryan White HIV/AIDS Program CLINICAL CONFERENCE, taking place Sunday, December 13, to Tuesday, December 15, at the Hyatt Regency in Seattle, WA. This year’s conference is co-chaired by Britt Gayle, MD, MPH, of the HIV/AIDS Bureau of the Health Resources and Services Administration in Rockville, Maryland; Shobha Swaminathan, [...]

The US Food and Drug Administration has approved doravirine 100 mg/islatravir 0.25 mg, a once-daily, single-tablet, 2-drug regimen for adults with virologically suppressed HIV-1. The regimen is indicated for individuals who have maintained viral suppression for at least 3 months, with no history of treatment failure or known resistance to doravirine. In phase III trials, the combination […]

We are pleased to announce that Shobha Swaminathan, MD, of Rutgers New Jersey Medical School, will serve as the third cochair for the 2026 Ryan White HIV/AIDS Program CLINICAL CONFERENCE, alongside Britt Gayle, MD, MPH, of the HIV/AIDS Bureau of the Health Resources and Services Administration in Rockville, Maryland, and Michael S. Saag, MD, of […]

The final presentation slides and the on-demand webcast recordings from The IAS–USA Annual Update on HIV Management in Atlanta, Georgia, are now available. CME credit will be available for this activity soon; please check back for updates. Click Here To View

CME credit claiming for CROI 2026 On Demand is now available—offering a flexible way to engage with conference content and earn credits, even if you did not attend the meeting.* Through this enduring activity, you can access selected sessions from CROI 2026 and earn up to 28.5 AMA PRA Category 1 Credits™ at $25 per [...]

In episode 74 of Going anti-Viral, Dr John Frater joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026.  Dr Frater is a Professor of Infectious Diseases at the University of Oxford where he [...]